about
UK guidelines for the management of bone sarcomasZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell linesBone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.Case report: Mesenchymal chondrosarcoma of the lumbar spine in a child.Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcomaUK Guidelines for the Management of Bone Sarcomas.A Rare and Interesting Case of a Massive Secondary Spinal Chondrosarcoma and Review of the Literature.Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist.Imaging pediatric bone sarcomas.Chondrosarcoma apoplexy in thoracic spine.Loss of β-catenin induces multifocal periosteal chondroma-like masses in miceDo Patients After Chondrosarcoma Treatment Have Age-appropriate Bone Mineral Density in the Long Term?Chondrosarcoma in the mental foramen region of the mandible: A case reportLow grade chondrosarcoma of the nasal septum.Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma.Unilateral lateral mass fixation of cervical spinal low-grade chondrosarcoma with intralesional resection: A case report.A systematic review and meta-analysis of intralesional versus wide resection for intramedullary grade I chondrosarcoma of the extremities.Chondrosarcoma of the hyoid bone: case report and review of current management options.Diversity of angiogenesis among malignant bone tumors.Management and prognostic significance of pathological fractures through chondrosarcoma of the femur.Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma.Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report.Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production.Versican V1 isoform regulates cell-associated matrix formation and cell behavior differentially from aggrecan in Swarm rat chondrosarcoma cells.Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies.Primary central chondrosarcoma of long bone, limb girdle and trunk: Analysis of 174 cases by numerical scoring on histology.Chondrosarcoma of the patella: A case reportChondrosarcoma of the hyoid bone: an atypical site of a sarcoma of the head and the neck.Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept.Suppression of hyaluronan synthesis attenuates the tumorigenicity of low-grade chondrosarcoma.Biology of Bone Sarcomas and New Therapeutic Developments.Clinical outcome of central conventional chondrosarcomaBone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upFOXA1 transcriptionally up-regulates cyclin B1 expression to enhance chondrosarcoma progression
P2860
Q26752425-4DBC7D05-E3AF-4EE9-960C-7272277F59BEQ28476074-76336E23-A48A-4962-8E3E-68BDDDE1165AQ33274572-15AFFEA0-1279-465B-85C8-FB9E20464B3DQ33685717-F5513B62-39DB-4E50-A56E-18C7DA22FEFAQ33793965-3281FADB-392D-452D-822D-1989432EC563Q33956334-DC1B223E-2825-48FD-9BD1-AEB91BC087DEQ34313986-BBB67BB6-2E1A-445B-9340-D84744371BB6Q34496992-D5ACD6DA-947A-423B-808E-29C2C7E6464EQ35612592-C5079AC2-538C-46D0-B42D-DF25EF4FC39BQ35820456-765022C3-D3D4-4C54-88F0-F3AAA73C2628Q36392814-C66D61D1-0A41-454C-9018-468245CB102AQ36499007-76DDE406-4DDD-497B-861D-0CA950344E12Q36628722-433CBA3F-9620-49EE-95F3-AAFEFF8007E6Q36676500-2B952CB9-3262-40E9-AA43-08419F60571FQ36904322-DA7B4F33-C9F9-4BA5-B230-5A1736BF4956Q37205983-18D40CAD-AF7B-481F-BD5E-A444D4E36A3FQ37354630-D7D7DC30-FAE7-4C28-AAA2-DD0AE731A7ADQ37563772-6D12B72F-AD5F-4E2F-B66B-5C3718041C23Q37719949-16C9570E-2D6E-4ADC-8DB5-E285961D8232Q37831828-D5787D49-2AA9-4E72-B35F-73070EB859C8Q38110465-2D1EBE59-E1EA-425F-ACE2-72B298C8AEB2Q38292264-55361CA0-673A-4EF6-AA2F-F571B81CBFE3Q38364816-D475F529-1F40-4312-953B-97F68EC8D50BQ38811197-F31B9598-AF08-40B4-871F-A56C1F2B42B5Q39252570-661D6832-91D3-426F-AFCB-FF70F8D9750DQ39393325-ADBA1D8E-E8D5-4286-A443-F33E6A4ADCC8Q39524896-975C86A7-8B1B-4932-86EF-9935839EC631Q39557265-0F1A3CE1-2D2D-410C-A8BF-04198A2D4D03Q41404897-8E002806-2685-4340-9358-D20E2C45262BQ41828455-6F35CE02-715C-451E-8FC4-9964068EFBF5Q43162529-B3C710D6-8814-43E4-8F68-8EA5FB4B0D09Q47121012-84618614-C2A8-4897-A5C9-F66F63CDFFB4Q47392155-14712ACF-CC1C-4A43-86E9-01FABE56FE2FQ48120956-0BE1A84C-1FF2-4A2D-BA18-2F4CAEC88184Q56979910-E8C78FAC-D44A-421E-9DD6-324D6AF63952Q57570627-D5674DDC-3773-4393-A679-A6E28D502CF9Q58790055-2D737F35-03A2-45A7-941C-99CC67BD1E5D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical management of chondrosarcoma.
@en
The clinical management of chondrosarcoma.
@nl
type
label
The clinical management of chondrosarcoma.
@en
The clinical management of chondrosarcoma.
@nl
prefLabel
The clinical management of chondrosarcoma.
@en
The clinical management of chondrosarcoma.
@nl
P2093
P1476
The clinical management of chondrosarcoma.
@en
P2093
Brian E Brigman
David Kirsch
Leslie Dodd
Nicole Larrier
Richard F Riedel
Salutario Martinez
P2860
P2888
P304
P356
10.1007/S11864-009-0088-2
P577
2009-02-24T00:00:00Z